26
CStone Pharma
2616.HK·HKEXSuzhou CNFounded 2015400 employees
Small CapbiotechPublicOncology
Platform: Sugemalimab IO
Market Cap
$0.5B
All Drugs
2
Clinical Trials
6
Failed / Terminated
3
FDA Approved
0
Stock Price & Catalysts (2616.HK)
Loading 2616.HK stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kemafotisoran | 261-8777 | Phase 3 | 2 | MALT1 | OCD | ||
| Polarasimod | 261-5079 | Phase 3 | 4 | GPRC5D | DMDIPF |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
CStone Pharma trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (6)